- Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.
- Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of protonpump inhibitor treatment: the Diamond study. Gut. 2010;59:714–21.
- Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.
- Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994;37;1265–82.
- Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum. 1994;24;29–39.
- Delaney JP, Michel HM, Bonsack ME, Eisenberg MM, Dunn DH. Adrenal corticosteroids cause gastric cell hyperplasia. Gastroenterology. 1979;76:913–16.
- Menguy R, Masters YF. Effect of cortisol on mucoprotein secretion by gastric antrum of dogs: pathogenesis of steroid ulcers. Surgery. 1963;54:19–28.
- Nampei A, Shi K, Ebina K, Tomita T, Sugamoto K, Yoshikawa H, et al. Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritis. J Clin Biochem Nurt. 2013;52:179–84.
- Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.
- Hung CS, Lee CL, Yang JN, Liao PT, Tu TC, Chen TK, et al. Clinical application of Carlsson’s questionnaire to predict erosive GERD among healthy Chinese. J Gastroenterol Hepatol. 2005;20:1900–5.
- Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United Eur Gastroenterol J. 2013;1:175–83.
- Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030–8.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al .The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
- Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheuatica. Ann Rheum Dis. 1979;38:434–9.
- Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;13:344–7.
- van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.
- Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996;23:2055–62.
- Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet. 1990;335:1078–80 [Review].
- Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19:424–30.
- Poirier TJ, Rankin GB. The gastrointestinal manifestation of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol. 1972;58:30–44.
- Yashiro K, Nagasako K, Hasegawa K, Maruyama M, Suzuki S, Obata H. Esophageal lesions in intestinal Behçet’s disease. Endoscopy. 1986;18:57–60.
- Brookes GB. Pharyngeal stenosis in Behçet’s syndrome: the first reported case. Arch Otolaryngol. 1983;109:338–40.
- Ruszniewski P, Soufflet C, Barthélémy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther. 2008;28:1134–9.
- Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991;18:188–94.
- Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients. J Rheumatol. 2000;27:1668–73.
- Janssen M, Dijkmans BA, van der Sluys FA, van der Wielen JG, Havenga K, Vandenbroucke JP, et al. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol. 1992;31:747–52.
- Wang K, Duan LP, Ge Y, Xu ZJ, Xia ZW. Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett’s esophagus, reflux esophagitis and non-erosive reflux disease. Zhonghua Yi Xue Za Zhi. 2011;91:1228–32.
- Lacy BE, Chehade R, Crowell MD. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless ph monitoring for the identification of gastroesophageal reflux. Am J Gastroenterol. 2011;106:1604–11.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research